Autofluorescence spectra of neoplastic tissues have been reported to be significantly different from those of normal tissues when excited by blue or violet light. From this concept, a lightinduced autofluorescence endoscopic imaging system for gastrointestinal mucosa (LIFE-GI; Xillix, Canada and Olympus, Japan) has been newly developed and the clinical evaluation of the prototype system has been conducted in hospitals in Canada, Netherlands and Japan.
INTRODUCTION
Neoplastic tissues have different autofluorescence spectra from normal tissues when excited by blue or violet light. This concept has been applied to form an image of neoplastic tissue, such as in early lung cancers [1] and colonic adenomas [2] . Sensitive photodetectors and the increasing capability of microcomputers have improved sensitivity, analytical selectivity, excitation-emission efficiency and ability to apply the properties of autofluorescence spectra to biological systems. Laser induced autofluorescence endoscopic imaging system (LIFELung) was developed for the detection of early cancerous or pre-cancerous lesions in the lung by Xillix Technologies Co. (Canada) and Olympus Optical Co. (Japan) and is used clinically with bronchoscopic procedures.
There are many reports that in the gastrointestinal tract the autofluorescence spectra of dysplasia and carcinomas are significantly different from those of normal mucosa [3] [4] [5] [6] [7] [8] [9] [10] . Based on the LIFE-Lung system, an autofluorescence imaging system for the gastrointestinal (GI) tract (LIFE-GI) has been newly developed by Xillix and Olympus based on the need for a more sensitive and specific method of real time detecting early cancer or precancerous lesion in the GI tract. Initial feasibility studies using a phase-1 prototype LIFE-GI instrument have been performed cooperatively in hospitals in Canada. Netherlands and Japan [11] [12] [13] [14] [15] . The schematic diagram of the LIFE-GI system is shown in Fig. 1 Figure 2 shows a case of colonic cancer.
The LIFE images ofthe lesion showed reddish color against the blue color of the normal mucosa. Figure 3 shows a colonic adenoma with a dark reddish color on the LIFE image. Figure 4 shows a hyperplastic polyp with a light reddish color on the LIFE image. Figure 5 is not neoplastic tissue but an inflammatory polyp with whitish blue color similar to normal mucosa in the LIFE image.
The relationship between the color of the autofluorescence image and the pathology of the biopsied specimen in colonic lesions is shown in Table I . Summarized results are: (i) adenocarcinoma appeared dark red; (ii) 84% of adenomas appeared dark red while the remaining appeared Fig. 6A . On the LIFE image (Fig. 6B ), a dark reddish area was recognized and a clear boundary was shown between the lesion and the normal mucosa. Biopsied specimen from the dark reddish area showed pathological adenocarcinoma and the lesion was resected surgically. The lesion was 38 x 27 mm in size and was very flat as shown in the loupe photomicrograph (Fig. 6C ). Pathological findings of this lesion (Fig. 6D) [17] . Twenty-six lesions, including all 20 carcinomas, showed abnormal fluorescence images as a reddish color on the LIFE-GI monitor and six of the lesions were benign tissues as determined by histological examination.
The system was applied for the detection of the remnant or recurrent lesions of patients after endoscopic treatment of early gastric cancer [14] . Although the diagnosis of complete resection is crucially important in endoscopic treatment for gastric neoplasm, it is sometimes very difficult to determine by conventional endoscopic observation whether the lesion is completely resected. Accordingly, we verified the usefulness of LIFE-GI system in the detection of small remnants of gastric neoplasm after endoscopic resection. Remnants of tumor after resection were suspected in 4 of the 12 lesions by the LIFE-GI system, 2 of which were proven histologically as adenocarcinoma, but could We also applied the LIFE-GI system to the patients with laterally spreading superficial colonic tumors, which were sometimes difficult to be detected by conventional endoscopy, and the lesions could be accurately diagnosed by the LIFE-GI system [18] .
From these clinical experiences, the indications of LIFE-GI system on the early diagnosis of gastrointestinal disease are summarized as in Table II. In conclusion, the real time autoflu0rescence endoscopy is a promising system to diagnose dysplastic lesions and early carcinomas in the GI tract as an adjunct to ordinary white light endoscopy. Moreover, this system, which needs no administration of a photosensitive agent, may be of use in screening for the early detection of cancers and/or pre-cancerous lesions.
The prototype LIFE-GI system, however, has several problems to be solved in order to apply this system to close examination oflesions. Instrumental false positive and negative imagings occurring mainly due to limited sensitivity of photodetectors, background quenching and photobleaching (loss of fluorescence intensity after light exposure) are among the problems to be solved. It is also important for the improvement of the system to identify the fluorescent molecules and clarify spectral properties of the molecules in determining pathological lesions.
